Evofem Biosciences, Inc.
(NASDAQ : EVFM)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen, Inc. -0.28%242.511.3%$863.30m
MRNAModerna, Inc. -3.55%66.800.0%$750.40m
NVAXNovavax, Inc. -1.90%108.0596.5%$693.90m
IMMUImmunomedics, Inc. 0.05%85.4511.0%$664.39m
GILDGilead Sciences, Inc. -0.37%63.971.0%$587.43m
REGNRegeneron Pharmaceuticals, Inc. 0.21%556.862.7%$451.14m
ILMNIllumina, Inc. -3.09%261.783.5%$375.51m
BIIBBiogen, Inc. 0.31%269.131.6%$337.06m
VRTXVertex Pharmaceuticals, Inc. -0.67%262.221.9%$327.87m
ALXNAlexion Pharmaceuticals, Inc. -0.33%111.382.0%$275.50m
SRNESorrento Therapeutics, Inc. -2.31%9.531.5%$271.42m
VXRTVaxart, Inc. -1.22%8.880.0%$253.83m
MNTAMomenta Pharmaceuticals, Inc. -0.04%52.353.0%$213.03m
SGENSeattle Genetics, Inc. -0.39%178.136.0%$203.03m
BMRNBioMarin Pharmaceutical, Inc. -1.07%76.454.3%$199.73m

Company Profile

Evofem Biosciences, Inc. develops therapeutic solutions to meet sexual and reproductive health needs of women. Its product include Amphora Contraceptive for the prevention of pregnancy, antimicrobial drug product for the prevention of sexually transmitted infections and Antimicrobial Drug product to prevent the reoccurrence of bacterial vaginosis. The company was founded in 2007 and is headquartered in San Diego, CA.